Where do conventional OADs stand.
Indian J Endocrinol Metab
; 16(Suppl 2): S252-5, 2012 Dec.
Article
en En
| MEDLINE
| ID: mdl-23565392
ABSTRACT
The last two decades have witnessed unprecedented activity in the field of OADs with many new drugs becoming available. Concerns with OAD include cardiovascular safety, fear about hypoglycemia, weight gain etc. In this article we attempt to review OADs , sulfonylureas in particular, in the light of the newer agents.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Indian J Endocrinol Metab
Año:
2012
Tipo del documento:
Article
País de afiliación:
India